(Q33927384)

30 July 2017

title

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study (English)

1 reference

prostate cancer screening

30 July 2017

main subject

1 reference

1 reference

corrigendum / erratum

Corrigendum to "Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study" [Eur Urol 2014;66:489-99].

1 reference

10.1016/J.EURURO.2014.12.001

Crossref

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1016/J.EURURO.2014.12.001

103

Zsofia Kote-Jarai

1 reference

30 July 2017

21

Cezary Cybulski

1 reference

30 July 2017

Vigdis Stefansdottir

76

0 references

Veda N Giri

Veda N Giri

82

0 references

David J Amor

David J Amor

79

0 references

Elena Castro

Elena Castro

3

0 references

David J Gallagher

David Gallagher

90

0 references

Anne-Bine Skytte

Anne-Bine Skytte

26

0 references

Nicola Nicolai

Nicola Nicolai

84

0 references

Geoffrey J. Lindeman

Geoffrey J Lindeman

61

0 references

Manuel R. Teixeira

Manuel R Teixeira

45

0 references

Hans Lilja

Hans Lilja

4

0 references

Ignacio Blanco

Ignacio Blanco

34

0 references

William David Foulkes

William D Foulkes

47

0 references

Hans Vasen

Hans Vasen

18

0 references

Andrew Vickers

Andrew Vickers

5

0 references

Rosalind Eeles

Rosalind A Eeles

116

0 references

Lambertus Kiemeney

Lambertus A Kiemeney

19

0 references

Gareth Evans

D Gareth Evans

13

0 references

Diana Eccles

Diana Eccles

15

0 references

Susan M Domchek

43

Susan Domchek

1 reference

30 July 2017

104

Jan Lubinski

1 reference

30 July 2017

55

Rita Schmutzler

1 reference

30 July 2017

58

Shirley Hodgson

1 reference

30 July 2017

99

Henrik Gronberg

1 reference

30 July 2017

Christi J van Asperen

17

Christi van Asperen

1 reference

30 July 2017

110

Gad Rennert

1 reference

30 July 2017

0 references

25

Anders Bojesen

1 reference

30 July 2017

38

Saundra Buys

1 reference

30 July 2017

Derek J Rosario

37

1 reference

ORCID Public Data File 2021

Teresa Ramón Y Cajal

66

Teresa Ramón y Cajal

1 reference

30 July 2017

93

Chris Bangma

1 reference

30 July 2017

22

Dominika Wokolorczyk

1 reference

30 July 2017

108

Anita V Mitra

1 reference

30 July 2017

71

Annelie Liljegren

1 reference

30 July 2017

29

Rogier Oldenburg

1 reference

30 July 2017

51

Louise Izatt

1 reference

30 July 2017

63

Marc Tischkowitz

1 reference

30 July 2017

53

Muriel A Adank

1 reference

30 July 2017

69

Allan Spigelman

1 reference

30 July 2017

39

Tom Conner

1 reference

30 July 2017

12

Karol Axcrona

1 reference

30 July 2017

20

Janneke Ringelberg

1 reference

30 July 2017

Rakefet Chen-Shtoyerman

78

Rakefet Chen-Shtoyerman

1 reference

30 July 2017

98

Alison Falconer

1 reference

30 July 2017

46

Sofia Maia

1 reference

30 July 2017

97

Jeanette Rothwell

1 reference

30 July 2017

73

Carole Brewer

1 reference

30 July 2017

80

Lucia Copakova

1 reference

30 July 2017

81

Julian Barwell

1 reference

30 July 2017

109

Clare Moynihan

1 reference

30 July 2017

68

Neus Gadea

1 reference

30 July 2017

49

Marielle Ruijs

1 reference

30 July 2017

102

Vincent Khoo

1 reference

30 July 2017

52

Rosemarie Davidson

1 reference

30 July 2017

7

Melissa Assel

1 reference

30 July 2017

Elizabeth K Bancroft

1

1 reference

30 July 2017

Elizabeth C Page

2

1 reference

30 July 2017

Daniel Sjoberg

6

1 reference

30 July 2017

Christopher S Foster

8

1 reference

30 July 2017

Gillian Mitchell

9

1 reference

30 July 2017

Kate Drew

10

1 reference

30 July 2017

Lovise Mæhle

11

1 reference

30 July 2017

Barbara Bulman

14

1 reference

30 July 2017

Donna McBride

16

1 reference

30 July 2017

Christina Selkirk

23

1 reference

30 July 2017

Peter J Hulick

24

1 reference

30 July 2017

Jimmy Lam

27

1 reference

30 July 2017

Louise Taylor

28

1 reference

30 July 2017

Ruben Cremers

30

1 reference

30 July 2017

Gerald Verhaegh

31

1 reference

30 July 2017

Wendy A van Zelst-Stams

32

1 reference

30 July 2017

Jan C Oosterwijk

33

1 reference

30 July 2017

Monica Salinas

35

1 reference

30 July 2017

Jackie Cook

36

1 reference

30 July 2017

Margreet G Ausems

40

1 reference

30 July 2017

Kai-ren Ong

41

1 reference

30 July 2017

Jonathan Hoffman

42

1 reference

30 July 2017

Jacquelyn Powers

44

1 reference

30 July 2017

Nassim Taherian

48

1 reference

30 July 2017

Apollonia T Helderman-van den Enden

50

1 reference

30 July 2017

Lisa Walker

54

1 reference

30 July 2017

Kathy Tucker

56

1 reference

30 July 2017

Judy Kirk

57

1 reference

30 July 2017

Marion Harris

59

1 reference

30 July 2017

Fiona Douglas

60

1 reference

30 July 2017

Janez Zgajnar

62

1 reference

30 July 2017

Virginia E Clowes

64

1 reference

30 July 2017

Rachel Susman

65

1 reference

30 July 2017

Nicholas Patcher

67

1 reference

30 July 2017

Theo van Os

70

1 reference

30 July 2017

Lucy Side

72

1 reference

30 July 2017

Angela F Brady

74

1 reference

30 July 2017

Alan Donaldson

75

1 reference

30 July 2017

Eitan Friedman

77

1 reference

30 July 2017

Vedang Murthy

83

1 reference

30 July 2017

Soo-Hwang Teo

85

1 reference

30 July 2017

Lynn Greenhalgh

86

1 reference

30 July 2017

Sara Strom

87

1 reference

30 July 2017

Alex Henderson

88

1 reference

30 July 2017

John McGrath

89

1 reference

30 July 2017

Neil Aaronson

91

1 reference

30 July 2017

Audrey Ardern-Jones

92

1 reference

30 July 2017

David Dearnaley

94

1 reference

30 July 2017

Philandra Costello

95

1 reference

30 July 2017

Jorunn Eyfjord

96

1 reference

30 July 2017

Freddie C Hamdy

100

1 reference

30 July 2017

Oskar Johannsson

101

1 reference

30 July 2017

Ulrika Axcrona

105

1 reference

30 July 2017

Jane Melia

106

1 reference

30 July 2017

Joanne McKinley

107

1 reference

30 July 2017

Mohnish Suri

111

1 reference

30 July 2017

Penny Wilson

112

1 reference

30 July 2017

Emma Killick

113

1 reference

30 July 2017

IMPACT Collaborators

114

1 reference

30 July 2017

Sue Moss

115

1 reference

30 July 2017

language of work or name

English

0 references

publication date

15 January 2014

1 reference

30 July 2017

1 reference

30 July 2017

volume

66

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

489-499

1 reference

Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Germline BRCA1 mutations increase prostate cancer risk

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Prostate-cancer mortality at 11 years of follow-up

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

28 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Screening and prostate-cancer mortality in a randomized European study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Mortality results from a randomized prostate-cancer screening trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

A review of targeted screening for prostate cancer: introducing the IMPACT study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Cancer Incidence in BRCA1 mutation carriers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Cancer risks in BRCA2 mutation carriers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Early detection of prostate cancer in African-American men with an increased familial risk of disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

A screening study of prostate cancer in high risk families

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Screening for prostate cancer in Dutch hereditary prostate cancer families.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Family history and prostate cancer screening with prostate-specific antigen

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105321

The impact of family history on early detection of prostate cancer

29 October 2018

1 reference

12 December 2020

Familial prostate cancer studies in Utah

1 reference

12 December 2020

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

1 reference

12 December 2020

Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families

1 reference

12 December 2020

Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval

1 reference

12 December 2020

Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives

1 reference

12 December 2020

Screening for prostate cancer in high risk populations

1 reference

12 December 2020

10.1016/J.EURURO.2014.01.003

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference